|会社名||Cowen Group Inc （コ―ウェン・グル―プ）|
|概要||事業概要 コーウェン(Cowen Inc.)(旧名:Cowen Group Inc.)は金融サービス会社である。同社は代替投資管理、投資銀行業務、研究、販売と取引、及びプライム・ブローカレッジ・サービスを提供する。同社は2つの事業を運営する。代替投資事業には、プライベート・エクイティ・ストラクチャ、登録済み投資会社及び上場投資ビークルが含まれる。ブローカー・ディーラー事業は、アドバイザリーとグローバル資本市場の創出とドメイン知識に基づく研究を含む成長を重視する企業向けの業界集中型投資銀行業務を提供し、機関投資家向けの販売・取引プラットフォームを提供する。ラミウスの名前で運営される代替投資プラットフォームは、機関投資家及び個人投資家向けの流動性スペクトラムを通じて投資商品とソリューションを提供する。ラミウスは投資家に、ロング/ショート・エクイティとイベント・ドリブン・エクイティを含む特定のニーズを満たす戦略へのアクセスを提供する。 コ―ウェン・グル―プは、米国の持株会社。子会社ラミナスを通じて、オルタナティブ投資、投資銀行業務、リサ―チ、セ―ルス・トレ―ディング業務等広範な金融サ―ビスを提供。ラミナス及びその関係会社がアルタナティブ投資を、コ―エン・アンド・カンパニ―及びその関係会社がブロ―カ―・ディ―ラ―業務を展開。 Cowen is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to its clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide.|
|本社所在地||599 Lexington Avenue New York NY 10022 USA|
|代表者氏名||Jeffrey M. Solomon ジェフリーM.ソロモン|
|代表者役職名||President Chief Executive Officer|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 Cowen Inc revenues increased 76% to $486M. Net income applicable to common stockholders increased from $7M to $18.9M. Revenues reflect Alternative Investment Banking segment increase from $67M to $408.6M. Net income benefited from Restructuring costs decrease from $8.5M (expense) to $0K Net realized and unrealized gains (losse increase of 13% to $44M (income). Dividend per share totaled to $14.06.|
Click Therapeutics to Participate in Cowens 6th Annual FutureHealth Conference 2021/06/16 11:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Click Therapeutics today announced that David Benshoof Klein, founder and CEO, will attend the upcoming Cowen 6th Annual FutureHealth Conference.
Two senior traders hired at Cowem Outsourced Trading 2021/06/15 13:29:06 InstitutionAlassetManager
Two senior traders hired at Cowem Outsourced Trading Submitted 15/06/2021 - 2:29pm Cowen has expanded its Fixed Income Outsourced Trading team with two senior hires, Vincent Governara and Chris Taliercio. Both traders bring over 15 years experience in the credit space at buy-side and sell-side institutions. Read the full story at Hedgeweek. Like this article? Sign up to our free newsletter Author Profile Tags Moves & Appointments
RBC adds Cowen clients to clearing platform 2021/06/15 12:08:48 The TRADE News
Through an agreement with Cowen, a subset of its clearing business will transition onto RBCs Clearing and Custody platform. The post RBC adds Cowen clients to clearing platform appeared first on The TRADE .
Cowen adds two credit traders to fixed income outsourced trading business 2021/06/15 11:05:05 The TRADE News
The two credit traders joining Cowen have both previously worked on the buy- and sell-side in senior trading positions. The post Cowen adds two credit traders to fixed income outsourced trading business appeared first on The TRADE .
Cowen Outsourced Trading Expands Fixed Income Team With Two Senior Traders 2021/06/15 11:00:00 Intrado Digital Media
NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- Cowen (NASDAQ:COWN) (Cowen or the Company) today announced the expansion of its Fixed Income Outsourced Trading team with two senior hires, Vincent Governara and Chris Taliercio. Both traders bring over 15 years experience in the credit space at buy-side and sell-side institutions.
The top 5 takeaways from psychedelics giant Atai’s 373-page IPO filing 2021/04/22 20:28:16 Business Insider
Summary List Placement Atai Life Sciences, the psychedelics giant backed by big name investors like Peter Thiel, is going public. The company was founded in 2018 and has gained momentum over the past few years, raising over $350 million from investors . In documents filed with the US Securities and Exchange Commission on Tuesday, Atai said it plans to trade on the Nasdaq under the symbol "ATAI." Atai's founders are Christian Angermayer, Florian Brand, Srinivas Rao, and Lars Christian Wilde. The company started as a vehicle to fund psychedelics companies like Compass Pathways, which is focused on developing psilocybin-based medications for treatment-resistant depression. Compass went public on the Nasdaq in September and now has a valuation of $1.2 billion. Atai owns 21.6% of Compass. Atai has developed into a biotech platform company, Brand told Insider in an interview last year, meaning it invests in and works closely with companies looking to develop medicines for mental-health conditions using psychedelics like psilocybin, arketamine, and ibogaine.
Some brands including Dunkin' and Eos lay out why they're making TikTok a mainstay in their ad budgets 2021/04/19 14:15:40 Business Insider
Summary List Placement TikTok has skyrocketed in popularity over the past year — and some advertisers are diving in. Eos increased its spending this year on TikTok to 15% of its digital ad budget, up from 6% in 2019, said Souyang Kang, Eos' chief marketing officer. Eos made the move after a video tutorial by creator Carly Joy went viral in February caused online orders to spike 25-fold. Eos has also used TikTok to drive in-app sales, and says TikTok is its fastest-growing digital and social commerce channel. "While some brands may think of it as experimental, TikTok is a core platform for us," said Kang. "Even when we tightened our budget amid the pandemic last year, we protected our TikTok investment. It's table stakes for us now." Aerie, meanwhile, plans to spend about 10% of its digital ad budget on TikTok this year from 2% in 2020, said Stacey McCormick, its SVP of marketing. Keith Lusby, Dunkin's VP of media, said it plans to double its spending on TikTok in 2021, without giving figures, and that TikTok now makes up more than 50% of its ad spend.
The key details every cannabis investor needs to know about New York's marijuana legalization bill, including the stocks to buy now 2021/03/29 17:18:17 Business Insider
Summary List Placement New York lawmakers have finally reached a deal to legalize marijuana for adults over the age of 21. Text of the bill was released on Saturday. State lawmakers including Sen. Liz Krueger say they expect a vote as early as this Tuesday. If it passes, New York will become the 15th state to legalize cannabis , following in the footsteps of its neighbor, New Jersey . It's the third time state legislators have tried to legalize marijuana , though hang-ups over taxation, impaired driving, and social equity provisions prevented earlier iterations from passing. Medical cannabis is already legal in New York. Adult-use cannabis won't be available immediately. Stifel analyst Andrew Carter said he expects adult-use sales to begin in late 2022. Analysts from Cantor Fitzgerald and Stifel estimate that New York could become a $5 billion cannabis market by 2025. Here's what you need to know about the bill and how to invest: Stocks to buy Right now, there are 10 medical cannabis licenses in New York .
Starbucks Gets Cowen Upgrade On Expectations Of Footfalls Reaching Pre-Pandemic Levels: What You Should Know 2021/03/18 03:07:00 Benzinga
The world’s largest coffee chain Starbucks Corp’s (NASDAQ: SBUX) customer visitation is expected to go back to pre-COVID-19 levels for when the …
Cowen Now the First U.S. Brokerage to Give ESG Scores on Equity Reports 2021/03/09 17:03:43 ETF Trends
Environmental, social, and governance (ESG) measures have not always been readily available in one identifiable metric. Yet according to a Reuters report, one U.S. brokerage is now the first to integrate an ESG score into company equity reports. The brokerage, Cowen, developed a simple score that runs from 1 to 100 with 50 representing a […] The post Cowen Now the First U.S. Brokerage to Give ESG Scores on Equity Reports appeared first on ETF Trends .
The world's largest cannabis companies are jockeying to dominate the lucrative US market. 7 top CEOs and executives break down the deals you can expect. 2021/02/25 14:23:10 Business Insider
Summary List Placement The US cannabis industry is set for a flurry of deals as Democrats on Capitol Hill make cannabis reform a core issue and new state markets open. Insider spoke with top executives at seven of the largest cannabis companies. They said that they'll be focused on expanding their footprints as new state markets open up. They also said they'd use deals to scoop up valuable intellectual property as they jockey for control of the lucrative US market. And there is another battle looming: Canadian companies like Canopy Growth, Aurora, Tilray, and Aphria, are all preparing to enter the US market as soon as they can, encroaching on US firms like Green Thumb Industries and Curaleaf. "These businesses, ours included, are going to become very big and very well-capitalized." Ben Kovler, the CEO of US cannabis company Green Thumb Industries (GTI) told Insider. In the US, cannabis is legal in 15 states for recreational purposes and in 36 states for medical use. Cowen analyst Vivien Azer has projected that the legal US cannabis industry could balloon to a $100 billion market by 2030, and companies are working hard to ensure that they'll win a slice of that.
Acceleron to Participate in Two Upcoming Healthcare Investor Conferences 2021/02/23 12:00:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that senior management will participate in two upcoming virtual healthcare investor conferences. Conference Presentation Details: Event: Cowen & Co. 41st Annual Health Care Conference Date/Time: Tuesday, March 2, 2021 at 2:50 p.m. EST Event: B
See the pitch deck that a Facebook engineer and a Wall Street analyst used to raise $2.5 million to build sorely needed software tools for the cannabis industry 2021/02/15 13:00:00 Business Insider
Summary List Placement When Stacey Hronowski first entered the cannabis space as a consultant for a Bay-area cannabis company, she says she was taken aback at the amount of manual work that businesses were doing just to keep track of their operations. "Even incredibly efficient founders were spending a lot of time on Google Sheets, on pen and paper, trying to keep track of their inventory," Hronowski told Insider. That's when she started to map out the idea for a compliance tool for the cannabis industry. Hronowski founded a company called Entrc, now called Canix, to address what she saw as a gap between the strict compliance regulations that cannabis companies needed to adhere to and the tools available to help. Canix closed a $2.5 million round on Monday to further grow operations. The company wants to become the top business-management software for cannabis companies, the founders said. The seed round was led by Phyto Partners, Floret Ventures, Andrew Freedman (Colorado's former cannabis czar), and others.
Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2% - Stocks News Feed 2021/02/12 15:59:21 Stocks News Feed
Following the market opening Friday, the Dow declined 0.09% to 31,402.67, while the NASDAQ fell 0.21% to 13,996.18. The S&P also plunged 0.05% to 3,914.51. Leading and Lagging Sectors Financials shares climbed 0.67% on Friday. Meanwhile, top gainers in the sector included Ambac Financial Group, Inc. (NYSE: AMBC), up 8.11%, and Cowen, Inc. (NASDAQ: COWN),… Read More »Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2%
Sage Therapeutics to Present at Upcoming Investor Conferences 2021/02/11 22:00:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $SAGE #Sage--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the following upcoming investor conferences: SVB Leerink Partners 10th Annual Global Healthcare Conference: on Thursday, February 25, 2021 at 8:00 am ET. Cowen & Co. 41st Annual Health Care Conference: on Mond
関連キーワード （投資銀行_証券サ―ビス 米国株 コ―ウェン・グル―プ COWN Cowen Inc.）